Aratana Therapeutic (PETX) Tops Q2 Expectations
Get Alerts PETX Hot Sheet
Join SI Premium – FREE
Aratana Therapeutic (NASDAQ: PETX) reported Q2 EPS of ($0.32), $0.04 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $150 thousand.
For earnings history and earnings-related data on Aratana Therapeutic (PETX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Walgreens Boosts Alliance (WBA) PT Lowered to $19 at Jefferies
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!